Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Carl Zeiss Meditec AG    AFX   DE0005313704

CARL ZEISS MEDITEC AG

(AFX)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • In a short-term perspective, the company has interesting fundamentals.
  • Carl Zeiss Meditec AG accounts for 4.99 % of our European Portfolio. A trade is currently open since 05/03/2019 with a purchase price of € 86.90. Discover the other 19 stocks of the European portfolio managed by the MarketScreener portfolio management team.
Strengths
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
  • The group usually releases upbeat results with huge surprise rates.
  • Sales forecast by analysts have been recently revised upwards.
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • The stock is in a well-established, long-term rising trend above the technical support level at 84.95 EUR
Weaknesses
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 53.45 times its estimated earnings per share for the ongoing year.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
Ratings chart
Sector Advanced Medical Equipment & Technology - NEC
1st jan.Capitalisation (M$)Investor Rating
CARL ZEISS MEDITEC AG49.34%10 086
THERMO FISHER SCIENTIFIC30.80%118 273
DANAHER CORPORATION38.02%100 898
INTUITIVE SURGICAL10.70%60 351
BOSTON SCIENTIFIC CORPORATI..19.75%58 421
EDWARDS LIFESCIENCES CORPOR..43.25%44 732
ILLUMINA, INC.-0.55%44 231
ROYAL PHILIPS41.11%42 643
SIEMENS HEALTHINEERS-1.42%38 821
SHENZHEN MINDRAY BIO-MEDL E..--.--%31 289
AGILENT TECHNOLOGIES13.25%23 875
CERNER CORPORATION29.94%21 574
RESMED17.62%18 779
OLYMPUS CORP-57.24%16 918
WATERS CORPORATION21.22%15 456
HOLOGIC21.65%13 218
More Results
Financials (EUR)
Sales 2019 1 428 M
EBIT 2019 264 M
Net income 2019 168 M
Finance 2019 665 M
Yield 2019 0,66%
P/E ratio 2019 53,5x
P/E ratio 2020 45,7x
EV / Sales2019 5,92x
EV / Sales2020 5,38x
Capitalization 9 123 M
Upcoming event on CARL ZEISS MEDITEC AG
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes